MyAverix Finance
F · Healthcare
IRLAB THERAP. AB A (6IRA)
Biotechnology
IRLAB THERAP. AB A (6IRA) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6IRA
IRLAB THERAP. AB A (6IRA) — FAQ
What is 6IRA's P/E ratio?
The price-to-earnings (P/E) ratio for IRLAB THERAP. AB A (6IRA) is 25.00 (data as of 2026-05-23).
Does IRLAB THERAP. AB A pay a dividend?
Dividend yield is not available in the current snapshot for IRLAB THERAP. AB A (6IRA). Check the MyAverix Finance app for the latest dividend data.
What sector is IRLAB THERAP. AB A in?
IRLAB THERAP. AB A (6IRA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6IRA listed on?
6IRA is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.